바이오포토닉스 시장 기회, 성장 촉진요인, 산업 동향 분석 및 예측(2025-2034년)

The Global Biophotonics Market was valued at USD 76.1 billion in 2024 and is estimated to grow at a CAGR of 11.3% to reach USD 220.1 billion by 2034. This remarkable growth trajectory is largely driven by rapid advancements in medical technology and the accelerating integration of nanotechnology across diagnostic and therapeutic platforms. The ability of nanotechnology to enhance light-matter interactions at the nanoscale has revolutionized the way biological systems are analyzed, making biophotonic devices more efficient and precise. These technologies now offer increased sensitivity and specificity when detecting biomarkers and imaging tissues, paving the way for more accurate diagnostics and tailored treatments, especially in early-stage disease detection.

With a growing emphasis on non-invasive procedures and real-time diagnostics, the demand for biophotonic innovations is surging across healthcare settings. The increasing global focus on personalized medicine, which relies heavily on precise molecular data, further reinforces the need for advanced optical technologies. Alongside technological evolution, the healthcare industry is witnessing greater investment in R&D, automation, and data-driven decision-making, which is helping streamline biophotonic applications across research, diagnostics, and treatment. Additionally, the rise in chronic conditions worldwide is prompting deeper exploration into efficient, accurate, and faster diagnostic methods-another factor contributing to the market's sustained expansion.

Based on technology, the market is bifurcated into In-Vitro and In-Vivo platforms. Among these, the In-Vitro segment is registering notable growth and is expected to reach USD 89.6 billion by 2034. This surge is primarily fueled by breakthroughs in lab-based diagnostics, as well as the integration of AI-driven analytics and automation. These advancements are minimizing human error, increasing operational efficiency, and making laboratory workflows more accurate and responsive. As the healthcare sector continues to prioritize early disease detection, the adoption of In-Vitro biophotonic platforms is expanding rapidly.

In terms of application, the market spans various segments, including see-through imaging, microscopy, inside imaging, spectro molecular, analytics sensing, light therapy, surface imaging, and biosensors. The spectro molecular segment held the dominant market share, valued at USD 15.1 billion in 2024. Its leadership in the segment is due to the evolution of spectroscopic tools that now offer enhanced sensitivity and diagnostic precision at the molecular level. These tools play a vital role in identifying biochemical changes linked to disease, thereby enabling early and more personalized intervention strategies.

From an end-use perspective, the market is segmented into tests and components, medical diagnostics, medical therapeutics, and non-medical applications. The tests and components segment accounted for the largest share at 35.4% in 2024, supported by rising demand for advanced diagnostic tools and precision imaging technologies.

Regionally, the United States leads the North American biophotonics market and is expected to achieve a valuation of USD 7.4 billion by 2034, thanks to heavy R&D spending, sophisticated healthcare infrastructure, and increasing demand for advanced diagnostic solutions in response to the growing burden of chronic illnesses.

The industry remains moderately consolidated, with top players like Thermo Fisher Scientific Inc., Carl Zeiss AG, Hamamatsu Photonics K.K., Olympus Corporation, and Oxford Instruments collectively controlling around 55%-60% of the market. These companies continue to invest in high-precision biophotonic technologies and expand their geographic footprint to reinforce their competitive edge.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Emergence of nanotechnology
    • 3.2.1.2 Aging population and growing lifestyle diseases
    • 3.2.1.3 Increasing use of biophotonics in cell and tissue diagnostics
    • 3.2.1.4 Increasing demand for home-based POC devices
    • 3.2.1.5 Rising integration with AI & ML
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of technology
    • 3.2.2.2 Slow rate of commercialization
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Future market trends
• 3.7 Gap analysis
• 3.8 Porter’s analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Technology, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 In-Vitro
• 5.3 In-Vivo

Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 See-Through imaging
• 6.3 Microscopy
• 6.4 Inside imaging
• 6.5 Spectro molecular
• 6.6 Analytics sensing
• 6.7 Light therapy
• 6.8 Surface imaging
• 6.9 Biosensors

Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Tests and components
• 7.3 Medical therapeutics
• 7.4 Medical diagnostics
• 7.5 Non-medical application

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 India
  • 8.4.3 Australia
  • 8.4.4 South Korea
  • 8.4.5 Japan
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 U.A.E.
  • 8.6.3 South Africa

Chapter 9 Company Profiles

• 9.1 Becton, Dickinson and Company
• 9.2 Carl Zeiss AG
• 9.3 Glenbrook Technologies
• 9.4 Hamamatsu Photonics K.K
• 9.5 IDEX
• 9.6 IPG Photonics Corporation
• 9.7 NU Skin Enterprises
• 9.8 Olympus Corporation
• 9.9 Oxford Instruments PLC
• 9.10 PerkinElmer Inc.
• 9.11 Thermo Fisher Scientific
• 9.12 TOSHIBA CORPORATION
• 9.13 Zecotek Photonics Inc.
• 9.14 Zenalux Biomedical Inc